Felipe_2023_Am.J.Transl.Res_15_6649

Reference

Title : Soluble epoxide hydrolase inhibitors for smoking-associated inflammatory lung diseases and chronic obstructive pulmonary disease: a meta-analytical systematic review of preclinical and clinical studies - Felipe_2023_Am.J.Transl.Res_15_6649
Author(s) : Felipe AGB , Miguel CB , Bernardes APL , Perissinotto R , Trindade-da-Silva CA , Martins-de-Abreu MC , Miguel-Neto J , Rodrigues WF , Oliveira CJF
Ref : Am J Transl Res , 15 :6649 , 2023
Abstract : Felipe_2023_Am.J.Transl.Res_15_6649
ESTHER : Felipe_2023_Am.J.Transl.Res_15_6649
PubMedSearch : Felipe_2023_Am.J.Transl.Res_15_6649
PubMedID: 38074809

Related information

Citations formats

Felipe AGB, Miguel CB, Bernardes APL, Perissinotto R, Trindade-da-Silva CA, Martins-de-Abreu MC, Miguel-Neto J, Rodrigues WF, Oliveira CJF (2023)
Soluble epoxide hydrolase inhibitors for smoking-associated inflammatory lung diseases and chronic obstructive pulmonary disease: a meta-analytical systematic review of preclinical and clinical studies
Am J Transl Res 15 :6649

Felipe AGB, Miguel CB, Bernardes APL, Perissinotto R, Trindade-da-Silva CA, Martins-de-Abreu MC, Miguel-Neto J, Rodrigues WF, Oliveira CJF (2023)
Am J Transl Res 15 :6649